Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2024-07-23 Regulatory Filings
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2024-07-23 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as the "Proceedings of 1st Extra Ordinary General Meeting (EGM) of the F.Y. 2024-25" held on 22nd July 2024. It details the meeting's commencement and conclusion times, lists directors and attendees, describes the meeting format (video conferencing), and summarizes the discussions and resolutions passed, including voting procedures and results. The document does not contain financial statements or detailed financial analysis but rather focuses on the official record of the EGM proceedings and resolutions. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document is not an announcement of a report but the actual proceedings and voting results of the EGM. Therefore, the correct classification is DVA.
2024-07-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a compliance letter addressed to stock exchanges (BSE and NSE) referencing SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It reports on the repayment of debentures and the process of delisting these debentures from the exchange. The document is short (2031 characters) and serves as an official notification of compliance and status update rather than a full financial report or detailed audit. It does not contain financial statements or detailed financial analysis. It is not an annual or interim report, nor an earnings release. It is also not a direct delisting announcement of the company's stock but rather a notice about the redemption and upcoming delisting of specific debt instruments (NCDs). Given the nature of the content and the regulatory compliance context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-20 English
Updates
Regulatory Filings
2024-07-16 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the listing compliance departments of BSE Limited and National Stock Exchange of India Limited. It references a corrigendum to the Extra-Ordinary General Meeting (EGM) notice dated June 28, 2024, and mentions the publication of newspaper advertisements regarding this corrigendum on July 13, 2024. The content is primarily about notifying the stock exchanges of the publication of these advertisements as per regulatory requirements. There is no substantive financial data, management discussion, or detailed report content. The document is essentially an announcement related to the publication of meeting notices and corrigenda, not the meeting materials themselves or voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous compliance announcements that do not fit other specific categories.
2024-07-13 English
Corrigendum
Regulatory Filings Classification · 95% confidence The document is a corrigendum to the notice of an Extra-Ordinary General Meeting (EGM) originally dated June 28, 2024. It details changes to the explanatory statement related to a preferential issue of fully convertible warrants, including the purpose and utilization of proceeds. The document is an update or correction to a previously issued meeting notice rather than the notice itself or the meeting outcome. It is not a full report, financial statement, or earnings release, but rather an amendment to a meeting notice. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-07-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.